David I. Marks - Concepedia

Author

David I. Marks

Also Known As

Dandoy, Christopher, David I Marks, David I. Marks, David Ian Marks, David MARKS, David Marks, Francesco Mangano, Freytes, Cesar O, Kamble, Rammurti, Kumar, Rajat

360

Publications

20.7K

Citations

H-Index

Concepts

All Affiliations

Medical College of Wisconsin The University of Texas MD Anderson Cancer Center Cleveland Clinic Vanderbilt University Medical Center Fred Hutch Cancer Center

About

David I. Marks is an author at Medical College of Wisconsin specializing in medicine, hematology, and transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	39	4.6K
2	Health Sciences	16	17	1.9K
3	Natural Sciences	2	2	91
4	Engineering	1	1	68
5	Nursing	1	1	46

David I. Marks

174

Publications

17.8K

Citations

H-Index

Page 1

	Year	Citations
Outcomes after Transplantation of Cord Blood or Bone Marrow from Unrelated Donors in Adults with Leukemia Mary J. Laughlin, Mary Eapen, Pablo Rubinstein, New England Journal of Medicine	2004	1.1K
Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study Adele K. Fielding, Susan Richards, Rajesh Chopra, Blood	2006	827
In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993) Anthony H. Goldstone, Susan Richards, Hillard M. Lazarus, Blood	2007	780
Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation Antonio Galleu, Yanira Riffo‐Vasquez, Cristina Trento, Science Translational Medicine Cell TherapyApoptosisImmunologyCell DeathPathology	2017	630
Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis Mary Eapen, Vanderson Rocha, Guillermo Sanz, The Lancet Oncology Acute LeukaemiaTransplantationMarrow TransplantationGraft SourceImmunology	2010	584
Effect of Age on Outcome of Reduced-Intensity Hematopoietic Cell Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission or With Myelodysplastic Syndrome Brian McClune, Daniel J. Weisdorf, Tanya L. Pedersen, Journal of Clinical Oncology Hematological MalignancyFirst Complete RemissionChronic GvhdTransplantationMarrow Transplantation	2010	477
Hematopoietic Stem-Cell Transplantation for Acute Leukemia in Relapse or Primary Induction Failure Michel Duval, John P. Klein, Wensheng He, Journal of Clinical Oncology Cell TherapyMixed-phenotype Acute LeukemiaBetter PrognosisPrimary Induction FailureAcute Leukemia	2010	437
T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993) David I. Marks, Elisabeth Paietta, Anthony V. Moorman, Blood	2009	409
Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation Navneet S. Majhail, Stephanie Farnia, Paul A. Carpenter, Biology of Blood and Marrow Transplantation	2015	403
UKALLXII/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemia Adele K. Fielding, Jacob M. Rowe, Georgina Buck, Blood	2013	365

Page 1